English | 简体中文 | 繁體中文 | 한국어
Share:
Orange Belgium : Transparency declaration - Norges Bank

Brussels, 19 May 2017 - Orange Belgium hereby discloses information in accordance with Article 14 of the Law of 2 May 2007 and the related Royal Decree of 14 February 2008:

On 18 May 2017, Orange Belgium received a transparency declaration from Norges Bank (the Central Bank of Norway), stating that, as of 17 May 2017, Norges Bank holds 1,826,314 shares (previous declaration: 1,691,216 shares), representing 3.04 % of the total share capital of the Company (previous declaration: 2.82 %).

An increase above (or decrease below) the following thresholds requires a declaration to Orange Belgium and the Financial Services and Markets Authority (FSMA):

  1. 3 % statutory threshold, as set out by the articles of association of the Company;
  2. 5 % or each multiple of 5 %, as set out by the Belgian law.

The complete text of this transparency declaration is also available on the « Shareholders & Investors » section of our website https://corporate.orange.be/en/financial-information.

About Orange Belgium

Orange Belgium is one of the leading telecommunication operators on the Belgian market, with over 3 million customers, and in Luxembourg through its subsidiary Orange Luxembourg.
As a convergent actor, we provide mobile telecommunication services, internet and TV to private clients, as well as innovative mobile and fixed line services to businesses. Our high-performance mobile network supports 2G, 3G, 4G and 4G+ technology and is the subject of ongoing investments.
Orange Belgium is a subsidiary of the Orange Group, one of the leading European and African operators for mobile telephony and internet access, as well as one of the world leaders for telecommunication services to enterprises.
Orange Belgium is listed on the Brussels Stock Exchange (OBEL).

More information on: https://corporate.orange.be/en, www.orange.be  or follow us on Twitter : @pressOrangeBe.

Contact investors
Siddy Jobe - ir@orange.be - +32(0)2 745 80 92





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Orange Belgium via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook  
Apr 21, 2018 00:30 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 21:33 ET
BOURBON: Positive progress in negotiations with lenders  
Apr 20, 2018 18:30 ET
Hubbell Incorporated Declares Regular Quarterly Dividend  
Apr 20, 2018 16:01 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 15:23 ET
Heineken Holding N.V. - Amendments to the Articles of Association  
Apr 20, 2018 15:18 ET
Lubrizol Presents Estane® TPU and Other Innovations for Consumer, Industrial, Footwear and Electronics Applications at Chinaplas 2018  
Apr 20, 2018 12:03 ET
Lipotec Active Ingredients Becomes Umbrella Brand  
Apr 19, 2018 23:43 ET
LEH PHARMA LTD.: Company Update  
Apr 18, 2018 19:34 ET
Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018  
Apr 18, 2018 19:33 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: